ELISA testing

Cellular Technology Limited (CTL) is described on its site as the pioneer and industry leader in the development, use, and manufacture of standardized immune monitoring tools, focused for over 25 years on advancing immune monitoring by ELISPOT/FluoroSpot (collectively called ImmunoSpot). It manufactures ImmunoSpot readers/analyzers in the USA to ISO 9001 standards and offers kits, media, PBMC samples, software, and CRO/contract lab services.

assay standardizationcell countingcolony countingconsultation and trainingcontract lab scanning and analysisELISPOT/FluoroSpot workshopsELISpot testingflow cytometry testingFluoroSpot testingimage analysismanufacture of immune monitoring analyzersneutralizing antibody (NAb) assayssample managementwhole blood processing to cryopreserved PBMC

Gamma Diagnostics is the global expert in Gamma Prime Fibrinogen (GPF), a biomarker for predicting clotting and inflammation in cardiovascular disease and other conditions such as COVID-19. Founder Dr. David Farrell and his team discovered GPF in 2010. The company offers the GammaCoeur CVD Risk ELISA Test System, a semi-automated quantitative ELISA method for detecting and assessing GPF in human venous plasma samples for clinical and research laboratories.

biomarker detectionrisk assessment

KCAS Bio is a bioanalytical contract research organization (CRO) providing GLP/GCP compliant development services for preclinical and clinical bioanalysis. It has supported more than 315 approved drugs, developed over 6,200 assays, and completed more than 20 FDA audits with no major findings. Lab facilities are located in Kansas City, Philadelphia, Lyon (France), and Melbourne (Australia).

AlphaLISAassay developmentassay validationELISpot testingFlow CytometryHybrid LC-MS/MSLC-UV-Vis/FluorescenceLigand Binding AssaysLiquid Chromatography Mass SpectrometryLuminexMeso Scale DiscoveryNULISAqPCR & ddPCRsample analysis